The FTO gene (e.g., rs9939609) is the most robustly replicated obesity-associated locus from GWAS. The risk allele (A) increases BMI by about 0.3–0.5 kg/m² per allele, primarily through increased appetite and preference for energy-dense foods. MyBody-X may test this variant, but the effect size is modest; lifestyle factors account for the majority of weight variation. Evidence for personalized nutrition based on FTO is limited: some studies suggest higher protein or fiber intake may attenuate the genetic risk, but findings are inconsistent. A consumer FTO test is not diagnostic and should not be used to prescribe a specific diet. Marketing claims of an 'FTO diet' are not supported by strong evidence. The test can raise awareness of a predisposition, but weight management still relies on established lifestyle interventions. Consumers should be cautious about overinterpreting results and seek professional guidance for meaningful changes.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-82d05d48f1617067ec255bff